ArticleWorld journal of surgical oncology2024

Neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy for human epidermal growth factor receptor 2 positive breast cancer: a real-world retrospective single-institutional study in China.

Dong-Mei Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.